)
)
)
PozeSCAF Inc
PozeSCAF Inc., a drug discovery company, has developed a series of First-in-class oncology assets—NM inhibitor candidates derived from our proprietary drug discovery Ax Drug platform Our Lead Asset is now approaching IND readiness. We are currently seeking a strategic partner or investor to advance these IND-ready assets for further clinical development studies
Address
BrooklynUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)